Your browser doesn't support javascript.
loading
SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers.
Jannier, Sarah; Kemmel, Véronique; Sebastia Sancho, Consuelo; Chammas, Agathe; Sabo, Amelia-Naomie; Pencreach, Erwan; Farace, Françoise; Chenard, Marie Pierre; Lhermitte, Benoit; Geoerger, Birgit; Aerts, Isabelle; Frappaz, Didier; Leblond, Pierre; André, Nicolas; Ducassou, Stephane; Corradini, Nadège; Bertozzi, Anne Isabelle; Guérin, Eric; Vincent, Florence; Velten, Michel; Entz-Werle, Natacha.
Afiliação
  • Jannier S; Pediatric Onco-Hematology Unit, University Hospital of Strasbourg, 67098 Strasbourg, France.
  • Kemmel V; Laboratory of Biochemistry, University Hospital of Strasbourg, 67098 Strasbourg, France.
  • Sebastia Sancho C; Laboratory of Pharmacology and Toxicology in Neurocardiology-EA7296, University of Strasbourg,67000 Strasbourg, France.
  • Chammas A; Radiology Department, Pediatric Unit, University Hospital of Strasbourg, 67098 Strasbourg, France.
  • Sabo AN; Radiology Department, Pediatric Unit, University Hospital of Strasbourg, 67098 Strasbourg, France.
  • Pencreach E; Laboratory of Biochemistry, University Hospital of Strasbourg, 67098 Strasbourg, France.
  • Farace F; Laboratory of Pharmacology and Toxicology in Neurocardiology-EA7296, University of Strasbourg,67000 Strasbourg, France.
  • Chenard MP; Oncobiology Platform, Laboratory of Biochemistry and Molecular Biology,University Hospital of Strasbourg, 67098 Strasbourg, France.
  • Lhermitte B; «Circulating Tumor Cells¼ Translational Platform, Gustave Roussy, University of Paris-Saclay,94800 Villejuif, France.
  • Geoerger B; Pathology Department, University Hospital of Strasbourg, 67098 Strasbourg, France.
  • Aerts I; Centre de Ressources Biologiques, University Hospital of Strasbourg, 67098 Strasbourg, France.
  • Frappaz D; Pathology Department, University Hospital of Strasbourg, 67098 Strasbourg, France.
  • Leblond P; Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay,INSERM U1015, 94800 Villejuif, France.
  • André N; Oncology Center SIREDO, Institut Curie, PSL Research University, 75005 Paris, France.
  • Ducassou S; Pediatric Oncology Department, Léon Berard Institute, 69373 Lyon, France.
  • Corradini N; Pediatric Oncology Department, Léon Berard Institute, 69373 Lyon, France.
  • Bertozzi AI; Pediatric Oncology Unit, Oscar Lambret Center, 59020 Lille, France.
  • Guérin E; Pediatric Onco-Hematology Unit, CHU La Timone, 13005 Marseille, France.
  • Vincent F; Pediatric Onco-Hematology Department, University Hospital of Bordeaux, 33000 Bordeaux, France.
  • Velten M; Pediatric Oncology Department, Léon Berard Institute, 69373 Lyon, France.
  • Entz-Werle N; Pediatric Oncology Unit, University Hospital of Nantes, 44093 Nantes, France.
Cancers (Basel) ; 12(10)2020 Oct 20.
Article em En | MEDLINE | ID: mdl-33092063
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França